Zhou Z - Search Results

1

Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.

Zhu L, Zhou Z, Mao H, Yang L. Zhu L, et al. Among authors: zhou z. Nanomedicine (Lond). 2017 Jan;12(1):73-87. doi: 10.2217/nnm-2016-0316. Epub 2016 Nov 23. Nanomedicine (Lond). 2017. PMID: 27876448 Free PMC article. Review.

2

IGF-1 receptor targeted nanoparticles for image-guided therapy of stroma-rich and drug resistant human cancer.

Zhou H, Qian W, Uckun FM, Zhou Z, Wang L, Wang A, Mao H, Yang L. Zhou H, et al. Among authors: zhou z. Proc SPIE Int Soc Opt Eng. 2016 Apr 17;9836:98361O. doi: 10.1117/12.2224914. Epub 2016 May 17. Proc SPIE Int Soc Opt Eng. 2016. PMID: 27313332 Free PMC article.

3

Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.

Qin Z, Wang J, Wang Y, Wang G, Wang X, Zhou Z, Liu G, Gao S, Zhu L. Qin Z, et al. Among authors: zhou z. Macromol Biosci. 2017 Apr;17(4). doi: 10.1002/mabi.201600335. Epub 2016 Nov 15. Macromol Biosci. 2017. PMID: 27862961

4

Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer.

Xu Z, Zhou Z, Yang X, Thakur A, Han N, Li HT, Li LG, Hu J, Li TF, Yan Y. Xu Z, et al. Among authors: zhou z. J Nanobiotechnology. 2024 Jul 20;22(1):429. doi: 10.1186/s12951-024-02694-z. J Nanobiotechnology. 2024. PMID: 39033109 Free PMC article.

5

Prospects of marine-derived compounds as potential therapeutic agents for glioma.

Liu Y, Zhou Z, Sun S. Liu Y, et al. Among authors: zhou z. Pharm Biol. 2024 Dec;62(1):513-526. doi: 10.1080/13880209.2024.2359659. Epub 2024 Jun 12. Pharm Biol. 2024. PMID: 38864445 Free PMC article. Review.

6

Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications.

Zhou Z, Peng B, Li J, Gao K, Cai Y, Xu Z, Yan Y. Zhou Z, et al. Sci Rep. 2021 Sep 15;11(1):18366. doi: 10.1038/s41598-021-97840-0. Sci Rep. 2021. PMID: 34526571 Free PMC article.

7

METTL3-mediated m⁶A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis.

Zhou Z, Cao Y, Yang Y, Wang S, Chen F. Zhou Z, et al. Epigenetics. 2023 Dec;18(1):2217033. doi: 10.1080/15592294.2023.2217033. Epigenetics. 2023. PMID: 37243702 Free PMC article.

8

A combined analysis of multi-omics data reveals the prognostic values and immunotherapy response of LAG3 in human cancers.

Peng J, Du Z, Sun Y, Zhou Z. Peng J, et al. Among authors: zhou z. Eur J Med Res. 2023 Dec 19;28(1):604. doi: 10.1186/s40001-023-01583-9. Eur J Med Res. 2023. PMID: 38115039 Free PMC article.

9

Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension.

Wei J, Zhou Z, Xu Z, Zeng S, Chen X, Wang X, Liu W, Liu M, Gong Z, Yan Y. Wei J, et al. Among authors: zhou z. PeerJ. 2019 Dec 10;7:e8188. doi: 10.7717/peerj.8188. eCollection 2019. PeerJ. 2019. PMID: 31844581 Free PMC article.

10

LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.

Liu SQ, Zhou ZY, Dong X, Guo L, Zhang KJ. Liu SQ, et al. Biosci Rep. 2020 Jul 31;40(7):BSR20200626. doi: 10.1042/BSR20200626. Biosci Rep. 2020. PMID: 32538432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,224 results

Search Page

Filters